跳至主要内容
临床试验/CTRI/2015/05/005773
CTRI/2015/05/005773招募中未知

An observational study to evaluate the hematological and hepatic adverse effects of long term low dose methotrexate therapy in Rheumatoid Arthritis patients of India - MTXSRA

institutional Dept of Pharmacology IPGMER0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Adult patients of age >= 18 years of either sex with a clinical diagnosis of rheumatoid arthritis as per American College of Rheumatology (ACR) 2010 guidelines.
  • 2.Patients on oral methotrexate therapy at a dose of <= 15mg weekly for >= 2 years duration.
  • 3.Patients on parenteral methotrexate therapy at a dose of <=15mg weekly for >= 2 years duration.
  • 4.Patients either on monotherapy with methotrexate or on combination therapy of methotrexate with any other DMARD or immunobiological agents.
  • 5.Subjects willing to give written informed consent and comply with study related instructions.

排除标准

  • Subjects who are on methotrexate therapy for less than 2 years.
  • 2. Subjects who are on methotrexate oral dose >15mg weekly or parenteral dose >15 mg weekly

研究者

发起方
institutional Dept of Pharmacology IPGMER

相似试验